AKTS
Aktis Oncology·NASDAQ
--
--(--)
--
--(--)
1.00 / 10
Underperform
The technical composite registers 1.0/10, evidencing challenging technical structure. Supportive evidence from no significant factors contends with contradictory data from Long Upper Shadow and Long Lower Shadow. Technical evaluation: cautious.
Analysis Checks(0/2)
Long Upper Shadow
Score1/10
Win Rate0.00%
Hist. Signals3
Avg Return-9.38%
Score1/10
Win Rate0.00%
Hist. Signals3
Avg Return-9.38%
Long Lower Shadow
Score1/10
Win Rate14.29%
Hist. Signals7
Avg Return-5.61%
Score1/10
Win Rate14.29%
Hist. Signals7
Avg Return-5.61%
Long Upper Shadow
Score1/10
Win Rate0.00%
Hist. Signals3
Avg Return-9.38%
Score1/10
Win Rate0.00%
Hist. Signals3
Avg Return-9.38%
Long Lower Shadow
Score1/10
Win Rate14.29%
Hist. Signals7
Avg Return-5.61%
Score1/10
Win Rate14.29%
Hist. Signals7
Avg Return-5.61%
Technical Analysis of AKTS?
- AKTS presents a Underperform setup with a Technical Score of 1.00/10. Key technical indicators highlight an RSI of 37.45 and a MACD of -0.26, with the trend anchored by the 50-Day SMA at 0.00. Traders should monitor key support at 18.87 and resistance at 20.48.
